date:Jul 30, 2015
ts derived from work in biotechnology. Some nations are demanding the time frame on patents be as little as five or eight years, whereas the U.S. says its standard 12-year buffer should apply because of the time and expense involved in creating such treatments.
That doesnt mean we have to fall into line and were not going to, said Mr. Robb, adding that he supported a five-year buffer. Theres a lot of tension running about the building here at the moment. Some very frank discussions. Mr. Robb sa